Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Cash & Equivalents (2016 - 2025)

Ingredion's Cash & Equivalents history spans 17 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 3.31% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, up 3.31%, while the annual FY2025 figure was $1.0 billion, 3.31% up from the prior year.
  • Cash & Equivalents reached $1.0 billion in Q4 2025 per INGR's latest filing, up from $915.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q4 2025 to a low of $236.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $552.9 million, with a median of $438.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: plummeted 50.68% in 2021, then skyrocketed 161.79% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $328.0 million in 2021, then dropped by 28.05% to $236.0 million in 2022, then surged by 69.92% to $401.0 million in 2023, then skyrocketed by 148.63% to $997.0 million in 2024, then rose by 3.31% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for INGR's Cash & Equivalents are $1.0 billion (Q4 2025), $915.0 million (Q3 2025), and $861.0 million (Q2 2025).